UAML
NKTR icon

US Asset Management LLC’s Nektar Therapeutics NKTR Stock Holding History

US Asset Management LLC’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,232
Closed -$23K – 125
2025
Q1 		$23K Hold
2,232
– – 0.02% 122
2024
Q4 		$31K Buy
+2,232
New +$39.4K 0.03% 122
2024
Q3 		– Sell
-2,524
Closed -$47K – 124
2024
Q2 		$47K Sell
2,524
-14
-0.6% -$295 0.04% 127
2024
Q1 		$36K Hold
2,538
– – 0.03% 132
2023
Q4 		$22K Buy
+2,538
New +$19.2K 0.02% 124
2023
Q2 		$22K Hold
2,531
– – 0.02% 123
2023
Q1 		$27K Buy
+2,531
New +$76.6K 0.03% 208

Other funds holding NKTR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

US Asset Management LLC's NKTR Position: Q2 2025 in Review

US Asset Management LLC sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 2,232 shares — an estimated $23K sold.

US Asset Management LLC first reported a position in NKTR in Q1 2023 and held it in 7 quarters. The position peaked at $47K in Q2 2024. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

  • US Asset Management LLC reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
  • US Asset Management LLC sold 2,232 Nektar Therapeutics shares in Q2 2025, an estimated $23K.
  • US Asset Management LLC first reported a position in Nektar Therapeutics in Q1 2023 and held it in 7 quarters.
  • US Asset Management LLC's Nektar Therapeutics position peaked at $47K in Q2 2024.
  • 109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on US Asset Management LLC's 13F filing for Q2 2025, filed 16 Jul 2025.